Back to Search
ANA-MARIA GONZALEZ-ANGULO, M.D.
M.D.
Medical Oncology Physician
NPI: 1497841720Individual
Specialties, Licenses & Credentials
Medical Oncology PhysicianPrimary
Internal Medicine — Medical Oncology
Code: 207RX0202X
L6917(TX)
Research & Publications (20)
Androgen receptor levels and association with PIK3CA mutations and prognosis in breast cancer.
PMID 19276248·Clin Cancer Res·2009
8-other
Using response to primary chemotherapy to select postoperative therapy: long-term results from a prospective phase II trial in locally advanced primary breast cancer.
PMID 19073507·Clin Breast Cancer·2008
3-trial
Defining prognosis for women with breast cancer and CNS metastases by HER2 status.
PMID 18334512·Ann Oncol·2008
8-other
Overview of resistance to systemic therapy in patients with breast cancer.
PMID 17993229·Adv Exp Med Biol·2007
6-review
Downregulation of the cyclin-dependent kinase inhibitor p27kip1 might correlate with poor disease-free and overall survival in inflammatory breast cancer.
PMID 17092400·Clin Breast Cancer·2006
8-other
Biologic markers in axillary node-negative breast cancer: differential expression in invasive ductal carcinoma versus invasive lobular carcinoma.
PMID 17239264·Clin Breast Cancer·2006
4-observational
Adjuvant therapy with trastuzumab for HER-2/neu-positive breast cancer.
PMID 16951389·Oncologist·2006
6-review
Factors predictive of distant metastases in patients with breast cancer who have a pathologic complete response after neoadjuvant chemotherapy.
PMID 16192593·J Clin Oncol·2005
8-other
Women age < or = 35 years with primary breast carcinoma: disease features at presentation.
PMID 15852360·Cancer·2005
8-other
Central nervous system metastases in patients with high-risk breast carcinoma after multimodality treatment.
PMID 15386311·Cancer·2004
4-observational
p53 expression as a prognostic marker in inflammatory breast cancer.
PMID 15448010·Clin Cancer Res·2004
8-other
Lack of association between amplification of her-2 and response to preoperative taxanes in patients with breast carcinoma.
PMID 15241821·Cancer·2004
8-other
Paclitaxel chemotherapy in a pregnant patient with bilateral breast cancer.
PMID 15507181·Clin Breast Cancer·2004
5-case
Integrative analysis of cyclin protein levels identifies cyclin b1 as a classifier and predictor of outcomes in breast cancer.
PMID 19470724·Clin Cancer Res·2009
8-other
Metformin and pathologic complete responses to neoadjuvant chemotherapy in diabetic patients with breast cancer.
PMID 19487376·J Clin Oncol·2009
8-other
AKT-independent signaling downstream of oncogenic PIK3CA mutations in human cancer.
PMID 19573809·Cancer Cell·2009
8-other
Prognostic impact of discordance between triple-receptor measurements in primary and recurrent breast cancer.
PMID 19596702·Ann Oncol·2009
8-other
Combined Src and aromatase inhibition impairs human breast cancer growth in vivo and bypass pathways are activated in AZD0530-resistant tumors.
PMID 19451593·Clin Cancer Res·2009
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 1515 HOLCOMBE BLVD, 77030-4009
HOUSTON, TX 77030 - Phone
- (713) 792-6161
Quick Facts
- NPI
- 1497841720
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile